5fpr

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (13:17, 26 July 2023) (edit) (undo)
 
(2 intermediate revisions not shown.)
Line 1: Line 1:
 +
==Structure of Bacterial DNA Ligase with small-molecule ligand pyrimidin-2-amine (AT371) in an alternate binding site.==
==Structure of Bacterial DNA Ligase with small-molecule ligand pyrimidin-2-amine (AT371) in an alternate binding site.==
-
<StructureSection load='5fpr' size='340' side='right' caption='[[5fpr]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
+
<StructureSection load='5fpr' size='340' side='right'caption='[[5fpr]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[5fpr]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FPR OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5FPR FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[5fpr]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Staphylococcus_aureus Staphylococcus aureus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FPR OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5FPR FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=LGA:PYRIMIDIN-2-AMINE'>LGA</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2&#8491;</td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5fp5|5fp5]], [[5fp6|5fp6]], [[5fpd|5fpd]], [[5fpe|5fpe]], [[5fpm|5fpm]], [[5fpn|5fpn]], [[5fpo|5fpo]], [[5fps|5fps]], [[5fpt|5fpt]], [[5fpy|5fpy]]</td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=LGA:PYRIMIDIN-2-AMINE'>LGA</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5fpr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fpr OCA], [http://pdbe.org/5fpr PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5fpr RCSB], [http://www.ebi.ac.uk/pdbsum/5fpr PDBsum]</span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5fpr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fpr OCA], [https://pdbe.org/5fpr PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5fpr RCSB], [https://www.ebi.ac.uk/pdbsum/5fpr PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5fpr ProSAT]</span></td></tr>
</table>
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/DNLJ_STAAU DNLJ_STAAU]
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
-
Herein we describe the application of fragment-based drug design to bacterial DNA ligase. X-ray crystallography was used to guide structure-based optimization of a fragment-screening hit to give novel, nanomolar, AMP-competitive inhibitors. The lead compound 13 showed antibacterial activity across a range of pathogens. Data to demonstrate mode of action was provided using a strain of S. aureus, engineered to overexpress DNA ligase.
+
Proteins need to be tightly regulated as they control biological processes in most normal cellular functions. The precise mechanisms of regulation are rarely completely understood but can involve binding of endogenous ligands and/or partner proteins at specific locations on a protein that can modulate function. Often, these additional secondary binding sites appear separate to the primary binding site, which, for example for an enzyme, may bind a substrate. In previous work, we have uncovered several examples in which secondary binding sites were discovered on proteins using fragment screening approaches. In each case, we were able to establish that the newly identified secondary binding site was biologically relevant as it was able to modulate function by the binding of a small molecule. In this study, we investigate how often secondary binding sites are located on proteins by analyzing 24 protein targets for which we have performed a fragment screen using X-ray crystallography. Our analysis shows that, surprisingly, the majority of proteins contain secondary binding sites based on their ability to bind fragments. Furthermore, sequence analysis of these previously unknown sites indicate high conservation, which suggests that they may have a biological function, perhaps via an allosteric mechanism. Comparing the physicochemical properties of the secondary sites with known primary ligand binding sites also shows broad similarities indicating that many of the secondary sites may be druggable in nature with small molecules that could provide new opportunities to modulate potential therapeutic targets.
-
Fragment-based discovery of 6-azaindazoles as inhibitors of bacterial DNA ligase.,Howard S, Amin N, Benowitz AB, Chiarparin E, Cui H, Deng X, Heightman TD, Holmes DJ, Hopkins A, Huang J, Jin Q, Kreatsoulas C, Martin AC, Massey F, McCloskey L, Mortenson PN, Pathuri P, Tisi D, Williams PA ACS Med Chem Lett. 2013 Oct 18;4(12):1208-12. doi: 10.1021/ml4003277. eCollection, 2013 Dec 12. PMID:24900632<ref>PMID:24900632</ref>
+
Detection of secondary binding sites in proteins using fragment screening.,Ludlow RF, Verdonk ML, Saini HK, Tickle IJ, Jhoti H Proc Natl Acad Sci U S A. 2015 Dec 11. pii: 201518946. PMID:26655740<ref>PMID:26655740</ref>
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
</div>
<div class="pdbe-citations 5fpr" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 5fpr" style="background-color:#fffaf0;"></div>
 +
 +
==See Also==
 +
*[[DNA ligase 3D structures|DNA ligase 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Jhoti, H]]
+
[[Category: Large Structures]]
-
[[Category: Ludlow, R F]]
+
[[Category: Staphylococcus aureus]]
-
[[Category: Pathuri, P]]
+
[[Category: Jhoti H]]
-
[[Category: Saini, H K]]
+
[[Category: Ludlow RF]]
-
[[Category: Tickle, I J]]
+
[[Category: Pathuri P]]
-
[[Category: Tisi, D]]
+
[[Category: Saini HK]]
-
[[Category: Verdonk, M]]
+
[[Category: Tickle IJ]]
-
[[Category: Williams, P A]]
+
[[Category: Tisi D]]
-
[[Category: Alternate binding site]]
+
[[Category: Verdonk M]]
-
[[Category: Antibiotic design]]
+
[[Category: Williams PA]]
-
[[Category: At371]]
+
-
[[Category: Fragment screening]]
+
-
[[Category: Ligase]]
+
-
[[Category: Protein-ligand complex]]
+

Current revision

Structure of Bacterial DNA Ligase with small-molecule ligand pyrimidin-2-amine (AT371) in an alternate binding site.

PDB ID 5fpr

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools